Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 6, Issue 1
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Research Article
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
Online download statistics by month:
Online download statistics by month: December 2019 to February 2024
Abstract
Full
Pdf
Dec 2019
1
1
0
Jan 2020
9
9
0
Feb 2020
22
22
1
Mar 2020
32
32
4
Apr 2020
21
21
9
May 2020
40
40
7
Jun 2020
26
26
3
Jul 2020
33
33
5
Aug 2020
25
23
2
Sep 2020
33
33
1
Oct 2020
47
47
9
Nov 2020
32
32
5
Dec 2020
48
48
6
Jan 2021
29
27
12
Feb 2021
46
46
3
Mar 2021
22
22
14
Apr 2021
33
33
5
May 2021
40
40
12
Jun 2021
28
28
6
Jul 2021
22
22
8
Aug 2021
12
12
6
Sep 2021
36
36
26
Oct 2021
24
24
23
Nov 2021
37
37
29
Dec 2021
20
22
11
Jan 2022
28
30
9
Feb 2022
27
30
21
Mar 2022
45
46
25
Apr 2022
34
35
12
May 2022
34
34
13
Jun 2022
39
39
21
Jul 2022
42
43
19
Aug 2022
43
44
10
Sep 2022
32
33
18
Oct 2022
66
69
27
Nov 2022
29
31
20
Dec 2022
42
42
14
Jan 2023
50
57
17
Feb 2023
57
57
11
Mar 2023
46
47
11
Apr 2023
24
26
11
May 2023
32
32
19
Jun 2023
20
20
6
Jul 2023
23
23
7
Aug 2023
14
14
4
Sep 2023
22
24
7
Oct 2023
39
39
13
Nov 2023
35
37
15
Dec 2023
20
20
10
Jan 2024
28
29
6
Feb 2024
46
46
20
Total
1635
1663
573
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?